ibrutinib
janssen,abbvie
['mantle,(-dismantle)', 'ibru', 'lymphoma']
the largest trial to date in mantle cell lymphoma shows that adding the #btkinhibitor ibrutinib to soc treatment improves pfs by 50%. #asco22 #asco2022
Medscape Oncology provides breaking medical news, references for drugs, diseases, and procedures, and free CME.